Mito-LND (Mito-Lonidamine) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito-LND inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells[1].
Molecular Weight:
801.62
Purity:
97.00
CAS Number:
[2361564-49-8]
Formula:
C43H45BrCl2N3OP
Target:
Autophagy,Mitochondrial Metabolism,Oxidative Phosphorylation,Reactive Oxygen Species (ROS)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
